Treatment Patterns of Follicular Lymphoma in the United States: A Claims Analysis
# Background A consensus is lacking on optimal treatment sequencing for follicular lymphoma (FL), the most common indolent lymphoma. FL is incurable, and many patients require multiple lines of therapy for successive relapses. Guidelines provide numerous recommendations for first-, second-, and thir...
Saved in:
| Main Authors: | Scott F. Huntington, Sreevalsa Appukkuttan, Wenyi Wang, Yuxian Du, Sari Hopson, Svetlana Babajanyan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Columbia Data Analytics, LLC
2022-10-01
|
| Series: | Journal of Health Economics and Outcomes Research |
| Online Access: | https://doi.org/10.36469/001c.38070 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-world treatment patterns and outcomes among patients initiating sequential regorafenib and trifluridine/tipiracil ± bevacizumab in patients with metastatic colorectal cancer in a US community setting (SEQRT2)
by: Tanios Bekaii-Saab, et al.
Published: (2025-06-01) -
Preferences of patients and physicians in the United States for relapsed/refractory follicular lymphoma treatments
by: Caitlin Thomas, et al.
Published: (2024-10-01) -
Treatment Patterns and Health Care Costs in Commercially Insured Patients with Follicular Lymphoma
by: Nathan H. Fowler, et al.
Published: (2020-09-01) -
Treatment patterns and outcomes in follicular lymphoma with POD24: an analysis from the LEO Consortium
by: Jonathan R. Day, et al.
Published: (2025-03-01) -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
by: Giuseppe Rossi, et al.
Published: (2016-11-01)